These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35618148)

  • 1. The impact of COVID-19 pandemic on individuals at clinical high-risk for psychosis: Evidence from eye-tracking measures.
    Zhang D; Guo Q; Xu L; Liu X; Zhang T; Liu X; Chen H; Li G; Wang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Aug; 118():110578. PubMed ID: 35618148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk.
    Zhang D; Xu L; Xie Y; Tang X; Hu Y; Liu X; Wu G; Qian Z; Tang Y; Liu Z; Chen T; Liu H; Zhang T; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):553-563. PubMed ID: 35857090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
    Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.
    Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF
    Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain network characteristics separating individuals at clinical high risk for psychosis into normality or psychosis.
    Choi SH; Kyeong S; Cho KIK; Yun JY; Lee TY; Park HY; Kim SN; Kwon JS
    Schizophr Res; 2017 Dec; 190():107-114. PubMed ID: 28325573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis.
    Santesteban-Echarri O; Liu L; Miller M; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
    Schizophr Res; 2022 Oct; 248():114-121. PubMed ID: 36030758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort.
    Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1379-1388. PubMed ID: 35113189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
    Lunsford-Avery JR; Gonçalves BDSB; Brietzke E; Bressan RA; Gadelha A; Auerbach RP; Mittal VA
    Schizophr Res; 2017 Nov; 189():37-42. PubMed ID: 28169087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.
    Daimer S; Mihatsch LL; Neufeld SAS; Murray GK; Knolle F
    Elife; 2022 Jul; 11():. PubMed ID: 35781372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived discrimination in those at clinical high risk for psychosis.
    Saleem MM; Stowkowy J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Addington J
    Early Interv Psychiatry; 2014 Feb; 8(1):77-81. PubMed ID: 23773288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of post-traumatic stress disorder and common mental disorders in health-care workers in England during the COVID-19 pandemic: a two-phase cross-sectional study.
    Scott HR; Stevelink SAM; Gafoor R; Lamb D; Carr E; Bakolis I; Bhundia R; Docherty MJ; Dorrington S; Gnanapragasam S; Hegarty S; Hotopf M; Madan I; McManus S; Moran P; Souliou E; Raine R; Razavi R; Weston D; Greenberg N; Wessely S
    Lancet Psychiatry; 2023 Jan; 10(1):40-49. PubMed ID: 36502817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lifetime traumatic experiences on suicidality and likelihood of conversion in a cohort of individuals at clinical high-risk for psychosis.
    Grivel MM; Leong W; Masucci MD; Altschuler RA; Arndt LY; Redman SL; Yang LH; Brucato G; Girgis RR
    Schizophr Res; 2018 May; 195():549-553. PubMed ID: 28935167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
    Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
    JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced interpersonal neural synchronization in right inferior frontal gyrus during social interaction in participants with clinical high risk of psychosis: An fNIRS-based hyperscanning study.
    Wei Y; Liu J; Zhang T; Su W; Tang X; Tang Y; Xu L; Qian Z; Zhang T; Li X; Wang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Jan; 120():110634. PubMed ID: 36099966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis.
    Thompson E; Kline E; Ellman LM; Mittal V; Reeves GM; Schiffman J
    Schizophr Res; 2015 Mar; 162(1-3):79-85. PubMed ID: 25638728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
    Seidman LJ; Giuliano AJ; Meyer EC; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Bearden CE; Christensen BK; Hawkins K; Heaton R; Keefe RS; Heinssen R; Cornblatt BA;
    Arch Gen Psychiatry; 2010 Jun; 67(6):578-88. PubMed ID: 20530007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.